Author:
Orkin C,Sadiq ST,Rice L,Jackson F,
Subject
Pharmacology (medical),Infectious Diseases,Health Policy
Reference15 articles.
1. 1 Mallal S , Phillips E , Carosi G et al. PREDICT-1: a novel randomized prospective study to determine the clinical utility of HLA-B*5701 screening to reduce abacavir hypersensitivity in HIV-1 infected subjects (study CNA106030). N Engl J Med 2008; 358: 568-579.
2. 2 Saag M , Balu R , Brachman P et al. High sensitivity of HLA-B*5701 in Whites and Blacks in immunologically confirmed cases of hypersensitivity (ABC HSR). Clin Infect Dis 2008; 46: 1111-1118.
3. 3 Campbell MC , Tishkoff SA. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Ann Rev Genom Hum Genet 2008; 9: 403-433.
4. 4 Sadiq ST , Pakianathan M. Uncertainties of routine HLA B*5701 testing in black African HIV cohorts in the UK. Sex Transm Inf 2007; 83: 173.
5. 5 Reeves I , Churchill D , Fisher M. Screening for HLA-B*5701 reduces the frequency of abacavir hypersensitivity reactions. Antivir Ther 2006; 11: L11.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献